Maryland’s biopharmaceutical companies research and develop new treatments and cures that improve patient health while also contributing to U.S. economic health. These companies employ highly skilled union construction workers to build state-of-the-art research and manufacturing facilities to ensure infrastructure is built to exacting standards.
Construction Employment
Union Labor & Earnings, 2015-20
Pharmaceutical & Biotech
Maryland Construction Labor Hours by Trade
Pharmaceutical & Biotech, 2015-20
33,150
Installation
9,109
Maintenance
42,259
Total hours
Largest Construction Projects
Pharmaceutical & Biotech Manufacturing, 2015-20
MedImmune LLC
660 Medimmune Ct, Frederick, MD 21703, USA
Frederick Manufacturing Center (FMC) Biologics Plant Building 636 Expansion
Frederick, MD
$250,000,000
2015-2017
Emergent BioSolutions Incorporated
5901 E Lombard St, Baltimore, MD 21224, USA
Baltimore Anthrax and Flu Vaccine Plant Expansion
Baltimore, MD
$150,000,000
2015-2018
Emergent BioSolutions Incorporated
5901 E Lombard St, Baltimore, MD 21224, USA
Baltimore Bayview Vaccine Bulk Covid-19 Plant Reno/Equipment Add
Baltimore, MD
$150,000,000
2020-2022
GlaxoSmithKline PLC
9911 Belward Campus Dr, Rockville, MD 20850, USA
Rockville Biopharmaceutical Benlysta Raxibacumab Autoimmune Plant Retrofit
Rockville, MD
$139,000,000
2017-2019
Paragon Bioservices, a Catalent Pharma Company
7565 Harmans Rd, Harmans, MD 21077, USA
Baltimore Gene Therapy CDMO Campus Single-Use System 7565 Harman Rd Expansion
Baltimore, MD
$130,000,000
2020-2022
Kite Pharma Incorporated
Ijamsville, MD, USA
Ijamsville (Urbana) Grassroot Chimeric Anitgen Receptor T (Car T) Plant
Ijamsville, MD
$105,000,000
2019-2022
United Therapeutics Corporation
United Therapeutics Silver Spring Campus, 1040 Spring St, Silver Spring, MD 20910, USA
Silver Spring Biologics Liquid Drug Substance Manufacturing Unit Addition
Silver Spring, MD
$85,000,000
2017-2018
Paragon Bioservices, a Catalent Pharma Company
801 W Baltimore St, Baltimore, MD 21201, USA
Baltimore Brownfield Cell/Gene Therapy & Vaccines Clinical Scale CDMO Plant
Baltimore, MD
$80,000,000
2018-2019
United Therapeutics Corporation
Silver Spring Biomedical Product Research Unisphere Building Expansion
Silver Spring, MD
$65,000,000
2016-2018
Novavax Incorporated
21 Firstfield Rd, Gaithersburg, MD 20878, USA
Gaithersburg Brownfield Pilot Covid-19 Vaccine Plant Conversion Phase 2
Gaithersburg, MD
$55,000,000
2020-2021
MedImmune LLC
Frederick Manufacturing Center (FMC) Biologics Plant Building 636 Expansion
Frederick, MD
Location
$250,000,000
Project Value
2015-2017
Years
MedImmune LLC
Frederick Manufacturing Center (FMC) Biologics Plant Building 636 Expansion
Emergent BioSolutions Incorporated
Baltimore Anthrax and Flu Vaccine Plant Expansion
Emergent BioSolutions Incorporated
Baltimore Bayview Vaccine Bulk Covid-19 Plant Reno/Equipment Add
Frederick, MD
Location
$250,000,000
Project Value
2015-2017
Years
Baltimore, MD
Location
$150,000,000
Project Value
2015-2018
Years
Baltimore, MD
Location
$150,000,000
Project Value
2020-2022
Years
GlaxoSmithKline PLC
Rockville Biopharmaceutical Benlysta Raxibacumab Autoimmune Plant Retrofit
Paragon Bioservices, a Catalent Pharma Company
Baltimore Gene Therapy CDMO Campus Single-Use System 7565 Harman Rd Expansion
Kite Pharma Incorporated
Ijamsville (Urbana) Grassroot Chimeric Anitgen Receptor T (Car T) Plant
Rockville, MD
Location
$139,000,000
Project Value
2017-2019
Years
Baltimore, MD
Location
$130,000,000
Project Value
2020-2022
Years
Ijamsville, MD
Location
$105,000,000
Project Value
2019-2022
Years
United Therapeutics Corporation
Silver Spring Biologics Liquid Drug Substance Manufacturing Unit Addition
Paragon Bioservices, a Catalent Pharma Company
Baltimore Brownfield Cell/Gene Therapy & Vaccines Clinical Scale CDMO Plant
United Therapeutics Corporation
Silver Spring Biomedical Product Research Unisphere Building Expansion
Silver Spring, MD
Location
$85,000,000
Project Value
2017-2018
Years
Baltimore, MD
Location
$80,000,000
Project Value
2018-2019
Years
Silver Spring, MD
Location
$65,000,000
Project Value
2016-2018
Years
Novavax Incorporated
Gaithersburg Brownfield Pilot Covid-19 Vaccine Plant Conversion Phase 2
Gaithersburg, MD
Location
$55,000,000
Project Value
2020-2021
Years
MedImmune LLC
Frederick Manufacturing Center (FMC) Biologics Plant Building 636 Expansion
Frederick, MD
Location
$250,000,000
Project Value
2015-2017
Years
Emergent BioSolutions Incorporated
Baltimore Anthrax and Flu Vaccine Plant Expansion
Baltimore, MD
Location
$150,000,000
Project Value
2015-2018
Years
Emergent BioSolutions Incorporated
Baltimore Bayview Vaccine Bulk Covid-19 Plant Reno/Equipment Add
Baltimore, MD
Location
$150,000,000
Project Value
2020-2022
Years
GlaxoSmithKline PLC
Rockville Biopharmaceutical Benlysta Raxibacumab Autoimmune Plant Retrofit
Rockville, MD
Location
$139,000,000
Project Value
2017-2019
Years
Paragon Bioservices, a Catalent Pharma Company
Baltimore Gene Therapy CDMO Campus Single-Use System 7565 Harman Rd Expansion
Baltimore, MD
Location
$130,000,000
Project Value
2020-2022
Years
Kite Pharma Incorporated
Ijamsville (Urbana) Grassroot Chimeric Anitgen Receptor T (Car T) Plant
Ijamsville, MD
Location
$105,000,000
Project Value
2019-2022
Years
United Therapeutics Corporation
Silver Spring Biologics Liquid Drug Substance Manufacturing Unit Addition
Silver Spring, MD
Location
$85,000,000
Project Value
2017-2018
Years
Paragon Bioservices, a Catalent Pharma Company
Baltimore Brownfield Cell/Gene Therapy & Vaccines Clinical Scale CDMO Plant
Baltimore, MD
Location
$80,000,000
Project Value
2018-2019
Years
United Therapeutics Corporation
Silver Spring Biomedical Product Research Unisphere Building Expansion
Silver Spring, MD
Location
$65,000,000
Project Value
2016-2018
Years
Novavax Incorporated
Gaithersburg Brownfield Pilot Covid-19 Vaccine Plant Conversion Phase 2
Gaithersburg, MD
Location
$55,000,000
Project Value
2020-2021
Years
